Lupin Limited has informed the Exchange about press release dated 25-Aug-2022 titled Lupin and I���rom Enter into an Exclusive Licensing Agreement for Denosumab biosimilar for Japan.
Lupin Limited has informed the Exchange about press release dated 25-Aug-2022 titled Lupin and I���rom Enter into an Exclusive Licensing Agreement for Denosumab biosimilar for Japan.